Cite
HARVARD Citation
Hybel, T. et al. (2022). CD38 is a potential treatment target in lymphoma patients concurrently infected with human immunodeficiency virus. Leukemia & lymphoma. 63 (6), pp. 1479-1483. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Hybel, T. et al. (2022). CD38 is a potential treatment target in lymphoma patients concurrently infected with human immunodeficiency virus. Leukemia & lymphoma. 63 (6), pp. 1479-1483. [Online].